Scinai Immunotherapeutics Ltd.(SCNI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SCNI Scinai Immunotherapeutics Ltd.

Trading 01-09 15:40:41 EST

0.7600

-0.0600

-7.32%

High0.8102	Low0.7600	Vol16.53K
Open0.8008	D1 Closing0.8200	Amplitude6.12%
Mkt Cap2.64M	Tradable Cap2.33M	Total Shares3.47M
T/O13.14K	T/O Rate0.54%	Tradable Shares3.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SCNI","market":"US","secType":"STK","nameCN":"Scinai Immunotherapeutics Ltd.","latestPrice":0.76,"timestamp":1767990689444,"preClose":0.82,"halted":0,"volume":16533,"delay":0,"floatShares":3061700,"shares":3468224,"eps":0.263692,"marketStatus":"Trading","change":-0.06,"latestTime":"01-09 15:40:41 EST","open":0.8008,"high":0.8102,"low":0.76,"amount":13144.8790836,"amplitude":0.06122,"askPrice":0.8,"askSize":199,"bidPrice":0.76,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.263692,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1767992400000},"marketStatusCode":2,"adr":0,"adrRate":4000,"listingDate":1431403200000,"exchange":"NASDAQ","adjPreClose":0.82,"postHourTrading":{"tag":"盘后","latestPrice":0.8053,"preClose":0.8053,"latestTime":"16:10 EST","volume":1,"amount":0.82,"timestamp":1767906605120},"volumeRatio":1.952425},"requestUrl":"/m/hq/s/SCNI","defaultTab":"news","newsList":[{"id":"2591682644","title":"This Is Why Scinai Immunotherapeutics Ltd.'s (NASDAQ:SCNI) CEO Compensation Looks Appropriate","url":"https://stock-news.laohu8.com/highlight/detail?id=2591682644","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591682644?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:57","pubTimestamp":1765803472,"startTime":"0","endTime":"0","summary":"Key Insights Scinai Immunotherapeutics to hold its Annual General Meeting on 22nd of December Total pay for CEO Amir...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-scni/scinai-immunotherapeutics/news/this-is-why-scinai-immunotherapeutics-ltds-nasdaqscni-ceo-co","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-scni/scinai-immunotherapeutics/news/this-is-why-scinai-immunotherapeutics-ltds-nasdaqscni-ceo-co","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","TSYW.SI","NQmain","USJW.SI","SCNI","TQQQ","QID","NVIW.SI",".IXIC","QLD","MNQmain","USAW.SI","PSQ","SQQQ","BK4139"],"gpt_icon":1},{"id":"2588674056","title":"Press Release: Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2588674056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588674056?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:50","pubTimestamp":1764683400,"startTime":"0","endTime":"0","summary":"JERUSALEM, Dec. 2, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company developing innovative inflammation and immunology (I&I) therapeutics and operating a growing boutique CDMO business unit, today reported its financial results and corporate highlights for the nine months ended September 30, 2025.-- Revenues for the nine months ended September 30, 2025 were $1,049. thousand, compared to $452 thousand for the nine months ended September. 30, 2024. The increase reflects continued expansion of Scinai Bioservices,$1,799 thousand, compared to $4,195 thousand for the nine months ended. employees and facility costs to the R&D business unit.-- Marketing, general and administrative expenses for the nine months ended. September 30, 2025 were $1,929 thousand, compared to $1,767 thousand for. were $607 thousand compared to financial income of $13,374 thousand for. by the financial income from loan conversion recorded in 2024.-- Net loss for the nine months ended Se","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","SCNI","BK4139","BK4007"],"gpt_icon":0},{"id":"2573667109","title":"Scinai Immunotherapeutics awarded grant from Israel Innovation Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=2573667109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573667109?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:40","pubTimestamp":1759750852,"startTime":"0","endTime":"0","summary":"Scinai Immunotherapeutics (SCNI) announced that it has been awarded a non-dilutive grant of approximately $246,000 from the Israel Innovation Autho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scinai-immunotherapeutics-awarded-grant-from-israel-innovation-authority-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scinai-immunotherapeutics-awarded-grant-from-israel-innovation-authority-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","SCNI"],"gpt_icon":0},{"id":"2573671131","title":"Press Release: Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2573671131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573671131?lang=en_us&edition=fundamental","pubTime":"2025-10-06 19:30","pubTimestamp":1759750200,"startTime":"0","endTime":"0","summary":"Grant funds two-thirds of a NIS 1.23 million  project to strengthen Scinai Bioservices' small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies in Israel and abroad. JERUSALEM, Oct. 6, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company with a growing boutique contract development and manufacturing organization  business unit, Scinai Bioservices, today announced that it has been awarded a non-dilutive grant of approximately NIS 809,000  from the Israel Innovation Authority . The grant will fund approximately 66% of a NIS 1.23 million  project aimed at acquiring and installing an advanced fill-and-finish system for sterile manufacturing. This investment addresses a major industry gap, as most early-stage biotech companies in Israel lack access to local, flexible, small-scale GMP manufacturing. As a result, many are forced to outsource overseas at high cost, with long lead times and limited control. Designed ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4139","CDMO","BK4007","BK4124","SCNI","TEN"],"gpt_icon":0},{"id":"2564658801","title":"Scinai Revenues For Six Months Ended Jun. 30 $773K vs $284K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2564658801","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564658801?lang=en_us&edition=fundamental","pubTime":"2025-09-02 19:35","pubTimestamp":1756812939,"startTime":"0","endTime":"0","summary":"Scinai Revenues For Six Months Ended Jun. 30 $773K vs $284K YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/09/47445427/scinai-revenues-for-six-months-ended-jun-30-773k-vs-284k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scinai.com","stockEarnings":[{"period":"1week","weight":0.1309},{"period":"1month","weight":-0.3506},{"period":"3month","weight":-0.4122},{"period":"6month","weight":-0.6521},{"period":"1year","weight":-0.7673},{"period":"ytd","weight":0.1309}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.1057},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.0111}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.100724},{"month":2,"riseRate":0.3,"avgChangeRate":-0.042165},{"month":3,"riseRate":0.3,"avgChangeRate":-0.014407},{"month":4,"riseRate":0.5,"avgChangeRate":0.075096},{"month":5,"riseRate":0.5,"avgChangeRate":0.025358},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.041702},{"month":7,"riseRate":0.545455,"avgChangeRate":0.067743},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.046786},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.108328},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.094214},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.010725},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.063466}],"exchange":"NASDAQ","name":"Scinai Immunotherapeutics Ltd.","nameEN":"Scinai Immunotherapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scinai Immunotherapeutics Ltd.(SCNI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Scinai Immunotherapeutics Ltd.(SCNI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Scinai Immunotherapeutics Ltd.,SCNI,Scinai Immunotherapeutics Ltd.股票,Scinai Immunotherapeutics Ltd.股票老虎,Scinai Immunotherapeutics Ltd.股票老虎国际,Scinai Immunotherapeutics Ltd.行情,Scinai Immunotherapeutics Ltd.股票行情,Scinai Immunotherapeutics Ltd.股价,Scinai Immunotherapeutics Ltd.股市,Scinai Immunotherapeutics Ltd.股票价格,Scinai Immunotherapeutics Ltd.股票交易,Scinai Immunotherapeutics Ltd.股票购买,Scinai Immunotherapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scinai Immunotherapeutics Ltd.(SCNI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Scinai Immunotherapeutics Ltd.(SCNI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}